Fraunhofer-Delaware Technology Summit
Fraunhofer, University of Delaware to host rescheduled tech summit March 5-6
2:20 p.m., Dec. 18, 2012--Product development challenges in two major sectors the life sciences and energy will be the focus of the inaugural Fraunhofer-Delaware Technology Summit, set for March 5–6, 2013, at the University of Delaware. Registration is available through the conference website.
Originally set for late October 2012 but postponed due to Hurricane Sandy, the technology summit will feature an exciting program of local to international speakers.
Tiny drug carriers
Exploring bacterial genes
The first day is a full-day conference at UD’s Clayton Hall Conference Center. The second day will feature laboratory tours and follow-up discussions. In addition to talks and panels, participants are encouraged to exhibit posters related to the conference topics, ranging from “Advances in Biopharmaceutical Manufacturing” to “Biomass-Derived Oils.” The deadline to submit a poster proposal is Feb. 25.
Keynote addresses will be delivered by Douglas Muzyka, senior vice president and chief science and technology officer at DuPont, who will speak on “Life Sciences Addressing Global Challenges,” and Lee Davis, senior vice president at NRG Energy, and president of NRG Energy Northeast, who will present “From Fossil to Photons: An Energy Company’s Transformation.”
“The summit will bring together leaders in basic research, translational sciences and industrial applications from across the Delaware Valley region and around the world,” said Karl Steiner, senior associate provost for research development at UD and conference co-organizer. “We are excited to have this unique opportunity for the scientific community to gather, network, get new ideas and move forward in solving some of society’s major challenges in energy and the life sciences.”
Fraunhofer is Europe’s largest application-oriented research organization, with initiatives focusing on health, security, communication, energy and the environment. It has more than 80 research units, including 60 Fraunhofer Institutes, and more than 20,000 staff, primarily engineers and scientists.
The Fraunhofer Center for Molecular Biotechnology (CMB), located in the Delaware Technology Park, is a subsidiary of Fraunhofer USA, conducting research and development in the area of plant biotechnology. Utilizing newly developed and cutting-edge technologies to advance products for infectious disease and autoimmune disorders in humans, CMB houses nearly 90 researchers with expertise in plant virology, molecular biology, protein engineering, protein biochemistry, immunology, quality management and regulatory functions.
The University of Delaware is classified by the Carnegie Foundation for the Advancement of Teaching as a research university with very high research activity a designation accorded less than 3 percent of U.S. colleges and universities.
UD ranks among the nation’s top 100 universities in federal research and development support for science and engineering. The University has more than 70 research centers, will open a new Interdisciplinary Science and Engineering Laboratory in 2013 and recently began phase-one development of the 272-acre Science, Technology and Advanced Research (STAR) campus.